Molecular Partners AG (XSWX:MOLN)
CHF 3.305 -0.115 (-3.36%) Market Cap: 108.63 Mil Enterprise Value: -74.61 Mil PE Ratio: 0 PB Ratio: 0.62 GF Score: 53/100

Half Year 2022 Molecular Partners AG Earnings Call Transcript

Aug 26, 2022 / 12:00PM GMT
Release Date Price: CHF5.94 (+0.34%)
Operator

Good day, and welcome to the Molecular Partners Second Quarter 2022 Half Year Report. (Operator Instructions) Please note this event is being recorded.

I would now like to turn the conference over to Seth Lewis, Senior Vice President of Investor Relations. Please go ahead.

Seth D. Lewis
Molecular Partners AG - SVP of IR, Communications & Strategy

Thanks, Jason. And welcome, everyone, to the Molecular Partners 2022 Half Year Results Conference Call. My name is Seth Lewis, and I'm joined today by our CFO, Andreas Emmenegger; and our CEO, Patrick Amstutz.

Today's call is a chance to catch up and recap the events of the first half of 2022 and is accompanied by the press release and half year report issued yesterday. If you've not had a chance to review these, they are available on our website, molecularpartners.com.

Following our prepared remarks, we will open for questions. And as a reminder, during today's call, management will be making certain forward-looking statements, and these statements involve risks and uncertainties that

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot